- Home
- Equipment
- canada alberta
- fetal maternal
Refine by
Fetal Maternal Equipment & Supplies In Canada Alberta
10 equipment items found
Manufactured by:Huntleigh Healthcare Ltd based inCardiff, UNITED KINGDOM
Designed to improve the standard of obstetric care, this new stylish design does not dominate the bedside, yet continues to offer a clear visual of the status of the fetus. The Sonicaid Team3 Series is easy to use and intuitive via the icon driven touchscreen, and the fetal heart rate can be displayed as “Big Numbers” and auto-scales depending on single, twins or ...
Manufactured by:EDAN Instruments, Inc. based inShenzhen, CHINA
F15 & F15 Air, the next generation of obstetric products. Advanced communication integrates fetal and maternal parameters to support monitoring in all phases. F15 series fetal and maternal monitor is the perfect combination of advanced technology and sophisticated algorithm for Obstetrics' new era. With state-of-art design, ...
Manufactured by:Datrend Systems Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
At just 5.5” x 3.6” x 1.3” and weighing only 11.5 ounces, the FMS-3 is a feature-packed Fetal/Maternal simulator. It’s smaller, lighter and more cost-effective than any other similarly-featured Fetal/Maternal simulator on the market ...
by:OBIX by Clinical Computer Systems, Inc based inHoffman Estates, ILLINOIS (USA)
Designed to fit in at the bedside, the OBIX BeCA® fetal monitor offers an accurate and clear visual of the status of the fetus and mother. The OBIX BeCA is easy to use and intuitive via the icon-driven touchscreen, and the fetal heart rate can be displayed as “Big Numbers” or in trace view, and auto-scales when monitoring twins for optimum ...
Manufactured by:Utah Medical Products, Inc based inMidvale, UTAH (USA)
Intran Plus is the original transducer-tipped intrauterine pressure catheter (IUPC) preferred by thousands of clinicians for its unrivaled accuracy, safety and reliability. The sensitive, single-use pressure transducer of Intran® Plus is located at the tip of the catheter that is placed inside the uterus. Placement of the transducer inside the uterus ensures that clinical decisions are based ...
Manufactured by:Medic Labor s.r.o. based inBratislava, SLOVAKIA
Dedicated random access prenatal screening platform from the leader in the field. DELFIA® Xpress has been developed to streamline workflows in laboratories and clinics providing prenatal screening services. Already in use in more than 50 countries, DELFIA Xpress offers a range of benefits critical for operational efficiency., The speed and flexibility of random access, The simplicity and ease ...
Manufactured by:Yourgene Health based inManchester, UNITED KINGDOM
The Sage™ Prenatal Screen is a non-invasive prenatal screening solution to estimate the risk of a fetus having Trisomy 21, Trisomy 18, Trisomy 13, Rare Autosomal Aneuploidies (RAA), Sex Chromosome Aneuploidies (SCA) and the most clinically relevant ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
TYVASO (treprostinil) is a prostacyclin mimetic indicated for the treatment of: Pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability. Studies establishing effectiveness predominately included patients with NYHA Functional Class III symptoms and etiologies of idiopathic or heritable PAH (56%) or PAH associated with connective tissue diseases (33%). The effects diminish ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Acetoacetic acid is an endogenous metabolite present in Cerebrospinal_Fluid and Blood that can be used for the research of Meningitis, Pregnancy, 3 Hydroxy 3 Methylglutaryl CoA Lyase Deficiency, Preeclampsia/Eclampsia, Diabetes Mellitus Type 2, Glucose Transporter Type 1 Deficiency Syndrome and Succinyl CoA:3 Oxoacid CoA Transferase ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases ...